Factors Surrounding Use of Antiresportive Agents and Xgeva

TON Interview with the Innovators: Volume 1 - Genitourinary Cancers, Video
Pam Skurkay, RN, BSN, CPAN, CURN
Dianna Shafer, BSN, CURN, CPN, CPC-I
Angela Hunter, BSN
Pam Skurkay talks about when providers consider prescribing one class of drugs versus another with factors that include the patient's insurance and overall health.
Related Items
Questions About Treating Patients on a CDK4/6 Inhibitor
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Use of Chemotherapy in the Metastatic Setting
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Mechanism of Action of CDK4/6 Inhibitors
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer
Hope S. Rugo, MD
Conference Correspondent  published on December 9, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
Matthew P. Goetz, MD
Conference Correspondent  published on December 8, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Hot Topics at SABCS 2017
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
HER2+ Breast Cancer and CDK4/6 Inhibitors
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Progressing on a CDK4/6 Inhibitor plus an Aromatase Inhibitor
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
What Differentiates Abemaciclib, Ribociclib, and Palbociclib?
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Last modified: October 3, 2016